Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > REGULATORY
REGULATORY
- Shuji Shirakawa of Kenporen Says Long-Listed Product Price Cuts Irrelevant to New Drug Development Premium
February 28, 2013
- Participation in TPP Talks “Will Not Damage” Japan’s Universal Health Insurance System: Health Minister Tamura
February 27, 2013
- PAFSC’s 2nd Committee Recommends Approval for CMIC’s Acute Porphyria Treatment
February 27, 2013
- JMACCT Revamps Database of Clinical Trial Institutions; Details Now Available Online
February 27, 2013
- MHLW Launches HQ to Promote Health and Medical Strategy
February 27, 2013
- Doctors' Average Monthly Wage Reaches 789,300 Yen in 2012, MHLW Survey Shows
February 25, 2013
- Govt Launches New Office of Health and Medical Strategy
February 25, 2013
- Ruling Parties’ Commission on Reduced Consumption Tax Rate System to Issue Interim Report This Summer
February 22, 2013
- MHLW Plans to Revise Ordinance within 2 to 3 Years to Allow Electronic Prescribing
February 22, 2013
- About 60% of Prefectures Won't Set Generic Share Targets in Medical Expenditure Optimization Plans
February 22, 2013
- MHLW to Examine Online OTC Drug Sales after Top Court Ruling
February 22, 2013
- EAD Director Kamata Calls for Early Price Settlements at Municipal Hospitals
February 21, 2013
- MHLW Eager to Submit Bill to Amend PAL to Diet by Summer, Councilor Hirayama Says
February 21, 2013
- Tokyo’s Katsushika Ward Allies with Wholesalers in Drug Procurement during Disasters
February 21, 2013
- Private-sector Members of Industrial Competitiveness Council Divided on Measures to Strengthen Innovation
February 20, 2013
- Prof. Morishita Calls for New Pricing System for Innovative Drugs; Doubling Prices Yielded by Current Cost Calculation Method
February 19, 2013
- 25 Companies Receive Approval for Generic Loxonin Tape, 11 Companies for Generic Calblock
February 19, 2013
- Regulatory Reform Council’s Priority Areas Include Health, Medicine; Discussion Topics to Be Set by Feb.-End
February 18, 2013
- Notification on Clinical Trial Documents and Records Cancels Previous Rules on Paper-Based “Original Documents and Duplicate Copies”
February 18, 2013
- MHLW Panel Kicks Off Discussion on New Rules for Online Drug Sales, Won’t Cover Ethical Products
February 15, 2013
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…